Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis

Archive ouverte

Danneels, P. | Rihet, C. | Vannier, C. | Quinqueneau, C. | Courtois, R. | Kempf, M. | Eveillard, M. | Mahieu, R. | Dubée, V.

Edité par CCSD ; Elsevier -

International audience. Endocarditis due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae is a rare but challenging condition. Its treatment relies on carbapenems alone or in combination, and no alternative has been described to date. The cephamycin cefoxitin has been used for treatment of mild ESBL-producing Enterobacteriaceae infections.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion